Preliminary Program: Sunday, May 23
7:30 a.m.-5 p.m.
Registration/Course Enrollment Open
7:30 a.m.-10 a.m.
Industry-Supported Symposia
8 a.m.-Noon
CME Courses 11-18
9 a.m.-10:30 a.m.
Workshops
W41. After a Parent's Suicide: Children's Grief and HealingChair: Nancy Rappaport, M.D.
W42. From Narrative and Theory to Evidence-Based Support for Psychiatrists Working Under Extreme StressAPA Lifers; Chair: Sheila Hafter Gray, M.D.
W43. Physician Heal Thyself: Scandals, Suicides, and Substance Abuse Among UsCo-Chairs: Margaret Bishop Baier, M.D., Scott Embley, L.C.S.W.
W44. Mood Disorders in Women of Reproductive AgeChair: Natalie Rasgon, M.D.
W46. Changing Paradigms of Psychiatric Practice in an Era of Health Care ReformAPA Council on Advocacy and Government Relations; Co-Chairs: Javeed Sukhera, M.D., Sarah Vinson, M.D.
W47. Ambulatory Medical Clinics as Training Sites for Residents and Fellows in Psychosomatic MedicineChair: Robert C. Joseph, M.D
9 a.m.-Noon
Symposia
S31. Understanding Personality Disorders in Children and Adolescents: Current Status and Future DirectionsAPA and AsPD Joint Symposium
| A. | Advancing From Understanding Personality Disorders in Young People Toward Early Detection and Intervention Andrew Chanen, M.B.B.S. | ||||
| B. | Why and Under What Circumstances Should We Make the Diagnosis of Personality Disorders in Children and Adolescents? Joel Paris, M.D. | ||||
| C. | Measurement and Assessment of PD precursors: Links to Normal Personality and Axis I Problems Jennifer Tackett, M.D. | ||||
S32. Treatment of Depression in Ethnic Minorities
| A. | Disparity in Depression Treatment Among Racial and Ethnic Minority Populations in the United States Margarita Alegria, Ph.D. | ||||
| B. | Diagnosing Depression in People of African Ancestry: National and International Perspectives William B. Lawson, M.D. | ||||
| C. | Ethical and Cultural Considerations in Treating Depression in Patients of Chinese Background Albert S. Yeung, M.D. | ||||
| D. | Use of Treatments for Depression Among Blacks, Latinos, and Caucasians Hector M. González, Ph.D. | ||||
S33. Approaches to Schizophrenia Through Phases of the Illness
| A. | Early Identification of the Psychosis Prodrome and Clinical Practice Kristin Cadenhead, M.D. | ||||
| B. | Management of First-Episode Schizophrenia John M. Kane, M.D. | ||||
| C. | Approaches to Schizophrenia Peter Weiden, M.D. | ||||
| D. | Evaluation and Intervention for the Persistently Ill Schizophrenic Person S. Charles Schulz, M.D. | ||||
S34. Diagnosing and Treating the Narcissistic Personality Disorder: AwaitingDSM-5 International Society for the Study of Personality Disorders
| A. | Observing Narcissistically Vulnerable Traits Mardi Horowitz, M.D. | ||||
| B. | Treatment Implications of the Proposed DSM-5 Representation of Narcissism Donna S. Bender, Ph.D. | ||||
| C. | A Self-Regulatory Model and Strategies for Treatment of Narcissistic Personality Disorder Elsa Ronningstam, Ph.D. | ||||
| D. | Promoting Awareness of Mental States and Their Triggers and Reducing Feelings of Rejection in Treatment of Narcissistic Pathology Giuseppe Giancarlo Dimaggio, M.D. | ||||
S35. Sex/Gender Differences and Women-Specific Issues in Drug Abuse: Predicting and Improving Treatment OutcomesNational Institute on Drug Abuse
| A. | Gender Differences in Psychiatric Comorbidity With Substance Use Disorder: Implications, Telescoping, and Treatment Kathleen Brady, M.D. | ||||
| B. | Significant Role of Sex-Based Biology in Predicting Relapse and Clinical Outcomes in Drug Abuse Rajita Sinha, Ph.D. | ||||
| C. | Women-Focused Treatment for Substance Use Disorders: Results From the Women's Recovery Group Study Shelly F. Greenfield, M.D. | ||||
| D. | Substance-Abusing Women With PTSD: How Best to Treat? Denise Hien, Ph.D. | ||||
| E. | The Use of Motivational Enhancement Therapy and Vouchers to Improve Treatment Utilization and Outcome in Pregnant Substance Users Theresa Winhusen, Ph.D. | ||||
9 a.m.-4 p.m.
Master Courses
MC03. Psychodynamic PsychotherapyChair: Glen O. Gabbard, M.D.
MC04. Practical Cognitive-Behavior TherapyChair: Jesse Wright, M.D., Ph.D.
CME Courses 19-31
Seminar 5
International Medical Graduates Residents Institute (Institute Registration Required)Co-Chairs: Nyapati Rao, M.D., Deborah Hales, M.D.
10 a.m.-4:30 p.m.
Exhibits Open
APA Member Center Open Publishers' Bookfair Open
11 a.m.-12:30 p.m.
Scientific and Clinical Reports Session 1. To Be Announced
Workshops
W48. Street to Home: SHAME in HomelessnessCo-Chairs: Prakash Chandra, M.D., Hina Tasleem, M.B.B.S.
W49. I'm Violent, Admit Me If You Dare: How and Where to Manage Potentially Violent Individuals With Unclear Diagnoses Presenting to Emergency ServicesCo-Chairs: Kenneth Certa, M.D., Jessica Mosier, M.D.
W50. Psychiatric Care in Lat in America: Current Challenges and Future PerspectivesCo-Chairs: Pedro Ruiz, M.D., Rodrigo A. Muñoz M.D.
W51. Update on Parasomnias: A Review for Psychiatric PracticeCo-Chairs: Dimitri Markov, M.D., Marina Goldman, M.D.
W52. Cultural Diversities: The Impact on Mental Health Treatment and Evaluation in Jails and PrisonsAPA Council on Psychiatry and Law; Chair: Henry Weinstein, M.D.
W53. Scope of Practice Challenges:Experiences, Successes, and Tribulations From Across the CountryCo-Chairs: Jerry Halverson, M.D., Claudia Reardon, M.D.
Noon-2:30 p.m.
Industry-Supported Symposia
12:30 p.m.-1:30 p.m.
Business Meeting and Forum (Open to APA voting members only.)
1 p.m.-5 p.m.
CME Courses 32-40
Seminar 6
Overview of Recovery for PsychiatristsChair: Mark Ragins, M.D.
1:30 p.m.-3 p.m.
Scientific and Clinical Reports
Session 2. To Be Announced
Session 3. To Be Announced
Workshops
W54. Making the Most of Your Chief Year: Chief Residents' Forum, Part 1Co-Chairs: Rex Huang M.D., Jonathan Horey, M.D.
W55. PromotingInternational Medical Graduates' Psychosocial Support During Residency TrainingCo-Chairs: Anu Matorin, M.D., Pedro Ruiz, M.D.
W56. Maintenance Treatment for Opiate Dependence: Terminable or Interminable?National Institute on Drug Abuse; Co-Chairs: Ivan Montoya, M.D., Herbert Kleber, M.D.
2 p.m.-3:30 p.m.
Lecture
L3. Manfred L. Guttmacher Award LectureRobert I. Simon, M.D., Kenneth Tardiff, M.D.
2 p.m.-4 p.m.
Symposia
S39. The Medical Home: Is There a Place for Psychiatry in It?APA Council on Children, Adolescents, and Their Families
| A. | A Primary Care Perspective Frank Degruy, M.D. | ||||
| B. | The Pediatric Medical Home: Where Does the Child and Adolescent Psychiatrist Fit In? Michael Houston, M.D. | ||||
| C. | Psychiatry and Primary Care Integration: Challenges and Opportunities Eliot Sorel, M.D. | ||||
S40. Privacy in Electronic Medical Records
| A. | Privacy Violations and Consequences Zebulon Taintor, M.D. | ||||
| B. | Privacy and Control in Health Information Exchanges: More than an Illusion? Glenn A. Martin, M.D. | ||||
| C. | The Perspective of Family Members on Privacy in Electronic Medical Records Edward F. Foulks, M.D. | ||||
| D. | Health IT and Privacy: Critical Pathways to Improving Mental Health Care Deven C. McGraw, J.D. | ||||
| E. | General Medical Views of Electronic Medical Record Privacy Laura Fochtmann, M.D. | ||||
S41. Health and Mental Health Around the World? Are All Systems Go?
| A. | The Canadian Health Care System: Pros and Cons Gail Robinson, M.D. | ||||
| B. | The Swiss Health System: Private Insurance and Solidarity Are Possible Olivier Halfon, M.D. | ||||
| C. | The French System: “Health Security” for All? Gisèle Apter, M.D. | ||||
2 p.m.-5 p.m.
S36. Treating Chronic Pain and Co-Occuring Addiction in SubstanceAbuse PatientsNational Institute on Drug Abuse
| A. | Why Do Some Patients Have Persistent Pain and Persistent Opioid Use Following Surgery: An Inception Cohort Study Ian Carroll, M.D. | ||||
| B. | Clinical Aspects of Risk Management in Opioid Therapy Steve Passik, Ph.D. | ||||
| C. | Behavioral Treatment for Co-Occurring Chronic Pain and Opioid Addiction Richard Schottenfeld, M.D. | ||||
| D. | Results of the Prescription Opioid Addiction Treatment Study: A Multi-Site Trial of the NIDA Clinical Trials Network Roger Weiss, M.D. | ||||
| E. | Overview of the Treatment of Acute and Chronic Pain in the Patient With a History of Addiction Sean Mackey, M.D. | ||||
S37. Culturally Sensitive Treatment of Psychologically Distressed Ethnic and Non-English-Speaking Populations
| A. | Efficacy of a Culturally Adapted Parent-Training Program for Ethnic Minority Families From Low-Income Communities Esther J. Calzada, Ph.D., Laurie Miller Brotman, Ph.D. | ||||
| B. | Culturally Sensitive Treatment of Traumatized Refugees and Ethnic Populations: Emotion Regulation Therapy for PTSD Devon E. Hinton, M.D., Ph.D., David H. Barlow, Ph.D., Michael W. Otto, Ph.D., Mark H. Pollack, M.D. | ||||
| C. | Adapting Psychosocial Treatments for Mexican Americans With Schizophrenia Alex Kopelowicz, M.D. | ||||
| D. | Using Culturally Adapted Motivational Interviewing to Improve Retention of Latino Outpatients in Antidepressant Therapy Roberto Lewis-Fernández, M.D. | ||||
| E. | Preventive Interventions for Refugee Families in Resettlement Stevan Weine, M.D. | ||||
S38. Neuroendocrine and Neuroimmunological Correlates of Bipolar Disorder in Women
| A. | Reproductive Endocrine Function in Women With Bipolar Disorder and Controls Natalie Rasgon, M.D., Ph.D. | ||||
| B. | Inflammatory and Oxidative Pathways in Mood Disorders: Novel Mechanisms and Therapeutic Opportunities Michael Berk, M.D., Ph.D. | ||||
| C. | Serum B12 Levels and Thyroid Function in Bipolar Disorder: Is There a Gender Difference? Aysegul Ozerdem, M.D., Ph.D. | ||||
| D. | Insulin Disturbance as a Critical Factor in Bipolar Disorder Roger McIntyre, M.D. | ||||
3 p.m.-4:30 p.m.
Scientific and Clinical Reports
Session 4. To be announced
Session 5. To be announced
Workshops
W57. Making the Most of Your Chief Year: Resident's Forum, Part IIChair: Rex Huang, M.D.
4:30 p.m.-6:30 p.m.
Opening Session and Presidential Address (Note new time.)
6 p.m.-8 p.m.
Industry-Supported Symposia
7 p.m.-10 p.m.
Media Workshop
MW2. Voicing the Unspeakable: Reflections on, and Discussion About, Overcoming Loss by SuicideChair: Sally Heckel, B.A.
